Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRING: aspirin or clopidogrel after intracerebral haemorrhage
ISRCTN16705062Phase 4Recruiting
- Sponsor
- University of Edinburgh
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of aspirin and clopidogrel in intracerebral hemorrhage (ICH) (2 arms), sponsored by University of Edinburgh. Primary endpoint: First occurrence of any major adverse cardiovascular event (MACE). Started Sep 2025; status: recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN16705062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16705062.